AAAAAA

   
Results: 1-18 |
Results: 18
Immunology of human papillomavirus infection in lower genital tract neoplasia
Authors: Man, S Fiander, A
Citation: S. Man et A. Fiander, Immunology of human papillomavirus infection in lower genital tract neoplasia, BEST P R CL, 15(5), 2001, pp. 701-714
Molecular and crystal structures of three berberine derivatives
Authors: Man, S Potacek, M Necas, M Zak, Z Dostal, J
Citation: S. Man et al., Molecular and crystal structures of three berberine derivatives, MOLECULES, 6(5), 2001, pp. 433-441
Human T-cell responses to HLA-A-restricted high binding affinity peptides of human papillomavirus type 18 proteins E6 and E7
Authors: Rudolf, MP Man, S Melief, CJM Sette, A Kast, WM
Citation: Mp. Rudolf et al., Human T-cell responses to HLA-A-restricted high binding affinity peptides of human papillomavirus type 18 proteins E6 and E7, CLIN CANC R, 7(3), 2001, pp. 788S-795S
Influenza A antigen exposure selects dominant V(beta)17(+) TCR in human CD8(+) cytotoxic T cell responses
Authors: Lawson, TM Man, S Williams, S Boon, ACM Zambon, M Borysiewicz, LK
Citation: Tm. Lawson et al., Influenza A antigen exposure selects dominant V(beta)17(+) TCR in human CD8(+) cytotoxic T cell responses, INT IMMUNOL, 13(11), 2001, pp. 1373-1381
Functional differences between influenza A-specific cytotoxic T lymphocyteclones expressing dominant and subdominant TCR
Authors: Lawson, TM Man, S Wang, ECY Williams, S Amos, N Gillespie, GM Moss, PA Borysiewicz, LK
Citation: Tm. Lawson et al., Functional differences between influenza A-specific cytotoxic T lymphocyteclones expressing dominant and subdominant TCR, INT IMMUNOL, 13(11), 2001, pp. 1383-1390
Berberine and coptisine in liquid ammonia
Authors: Man, S Dostal, J Necas, M Zak, Z Potacek, M
Citation: S. Man et al., Berberine and coptisine in liquid ammonia, HETEROCYC C, 7(3), 2001, pp. 243-248
Clinical studies of human papilloma vaccines in pre-invasive and invasive cancer
Authors: Adams, M Borysiewicz, L Fiander, A Man, S Jasani, B Navabi, H Lipetz, C Evans, AS Mason, M
Citation: M. Adams et al., Clinical studies of human papilloma vaccines in pre-invasive and invasive cancer, VACCINE, 19(17-19), 2001, pp. 2549-2556
Antigen processing defects in cervical carcinomas limit the presentation of a CTL epitope from human papillomavirus 16 E6
Authors: Evans, M Borysiewicz, LK Evans, AS Rowe, M Jones, M Gileadi, U Cerundolo, V Man, S
Citation: M. Evans et al., Antigen processing defects in cervical carcinomas limit the presentation of a CTL epitope from human papillomavirus 16 E6, J IMMUNOL, 167(9), 2001, pp. 5420-5428
Defined flanking spacers and enhanced proteolysis is essential for eradication of established tumors by an epitope string DNA vaccine
Authors: Velders, MP Weijzen, S Eiben, GL Elmishad, AG Kloetzel, PM Higgins, T Ciccarelli, RB Evans, M Man, S Smith, L Kast, WM
Citation: Mp. Velders et al., Defined flanking spacers and enhanced proteolysis is essential for eradication of established tumors by an epitope string DNA vaccine, J IMMUNOL, 166(9), 2001, pp. 5366-5373
Multicellular gastric cancer spheroids recapitulate growth pattern and differentiation phenotype of human gastric carcinomas
Authors: Mayer, B Klement, G Kaneko, M Man, S Jothy, S Rak, J Kerbel, RS
Citation: B. Mayer et al., Multicellular gastric cancer spheroids recapitulate growth pattern and differentiation phenotype of human gastric carcinomas, GASTROENTY, 121(4), 2001, pp. 839-852
Recognition of human tumours: viral antigens as immunological targets for cytotoxic T cells
Authors: Man, S
Citation: S. Man, Recognition of human tumours: viral antigens as immunological targets for cytotoxic T cells, IMMUNOL MED, 30, 2001, pp. 123-145
Lack of multicellular drug resistance observed in human ovarian and prostate carcinoma treated with the proteasome inhibitor PS-341
Authors: Frankel, A Man, S Elliott, P Adams, J Kerbel, RS
Citation: A. Frankel et al., Lack of multicellular drug resistance observed in human ovarian and prostate carcinoma treated with the proteasome inhibitor PS-341, CLIN CANC R, 6(9), 2000, pp. 3719-3728
Loss of heterozygosity in bilateral breast cancer
Authors: Kollias, J Man, S Marafie, M Carpenter, K Pinder, S Ellis, IO Blamey, RW Cross, G Brook, JD
Citation: J. Kollias et al., Loss of heterozygosity in bilateral breast cancer, BREAST CANC, 64(3), 2000, pp. 241-251
Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity
Authors: Klement, G Baruchel, S Rak, J Man, S Clark, K Hicklin, DJ Bohlen, P Kerbel, RS
Citation: G. Klement et al., Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity, J CLIN INV, 105(8), 2000, pp. R15-R24
Human papillomavirus type 16 E6/E7-specific cytotoxic T lymphocytes in women with cervical neoplasia
Authors: Bontkes, HJ de Gruijl, TD van den Muysenberg, AJC Verheijen, RHM Stukart, MJ Meijer, CJLM Scheper, RJ Stacey, SN Duggan-Keen, MF Stern, PL Man, S Borysiewicz, LK Walboomers, JMM
Citation: Hj. Bontkes et al., Human papillomavirus type 16 E6/E7-specific cytotoxic T lymphocytes in women with cervical neoplasia, INT J CANC, 88(1), 2000, pp. 92-98
Use of fluorogenic histocompatibility leukocyte antigen-A0201/HPV 16 E7 peptide complexes to isolate rare human cytotoxic T-lymphocyte-recognizing endogenous human papillomavirus antigens
Authors: Youde, SJ Dunbar, PRR Evans, EML Fiander, AN Borysiewicz, LK Cerundolo, V Man, S
Citation: Sj. Youde et al., Use of fluorogenic histocompatibility leukocyte antigen-A0201/HPV 16 E7 peptide complexes to isolate rare human cytotoxic T-lymphocyte-recognizing endogenous human papillomavirus antigens, CANCER RES, 60(2), 2000, pp. 365-371
A family of Eulerian-Lagrangian localized adjoint methods for multi-dimensional advection-reaction equations
Authors: Wang, H Ewing, RE Qin, G Lyons, SL Al-Lawatia, M Man, S
Citation: H. Wang et al., A family of Eulerian-Lagrangian localized adjoint methods for multi-dimensional advection-reaction equations, J COMPUT PH, 152(1), 1999, pp. 120-163
The use of human leucocyte antigen class I transgenic mice to investigate human immune function
Authors: Faulkner, L Borysiewicz, LK Man, S
Citation: L. Faulkner et al., The use of human leucocyte antigen class I transgenic mice to investigate human immune function, J IMMUNOL M, 221(1-2), 1998, pp. 1-16
Risultati: 1-18 |